Back
KLBF - Kalbe Farma

KLBF - Net profit grew 10.97% yoy in 9M25

28 October 2025

KLBF - Net profit grew 10.97% yoy in 9M25 Kalbe Farma (KLBF) booked a net profit of IDR2.63 tn in 9M25, up 10.97% yoy, supported by solid growth across its key business segments. Revenue rose 7.22% yoy to IDR25.98 tn, driven by higher sales in prescription drugs (+11.03%), health products (+9.45%), and distribution & logistics (+10.41%). The nutrition segment remained weak, declining 2.1% yoy to IDR6.04 tn, prompting management to revise its FY25 revenue growth target to 6–8% from the previous 8–10%. Gross profit reached IDR10.55 tn, while total assets climbed to IDR30.10 tn, reflecting steady balance sheet expansion amid higher short-term liabilities. (Source : Bisnis Indonesia)

Related Research

Consumer
KLBF - Expects a Brighter 24F, after a weak 23f
Andre Suntono 20 March 2024 See Detail
Healthcare
KLBF - 9M25 results came in-line on solid 3Q25 sales growth
Andre Suntono 31 October 2025 See Detail
Consumer
KLBF - Terus bertumbuh di kuartal II/2022
Winny Rahardja 05 August 2022 See Detail